Dolby Named to Fast Company's Annual List of the World's Most Innovative Companies List for Fourth Time Accessibility StatementSkip Navigation Dolby Vision 2 recognized in the Consumer Electronics category as a revolutionary leap forward for picture quality SAN FRANCISCO, March 24, 2026 /PRNewswire/ -- Dolby Laboratories, Inc.(NYSE: DLB) is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2026. This year's list shines a spotlight on businesses that are ...

Core Insights - New analyses indicate that dementia with Lewy bodies (DLB) patients with lower plasma pTau181 levels experienced greater clinical benefits from neflamapimod in a Phase 2b clinical trial, suggesting a potential to target the underlying disease biology [1][2][5] - The findings support the company's patient enrichment strategy and dosing regimen for the upcoming Phase 3 trial [1][2] Clinical Trial Details - The RewinD-LB Phase 2b trial included an initial randomized phase comparing neflamapimod to placebo, followed by a neflamapimod-only extension phase [3][10] - In the initial phase, participants did not achieve expected plasma drug concentration levels, resulting in no statistically significant improvement on the primary endpoint [3][4] - The extension phase with a new batch of capsules (DP Batch B) showed statistically significant and clinically meaningful slowing of clinical progression compared to the initial batch [4] Treatment Response and Biomarkers - Treatment response increased progressively across DLB patient subgroups with lower plasma pTau181 levels, indicating a higher likelihood of patients without Alzheimer's disease (AD) co-pathology [2][5] - The analyses revealed a strong association between neflamapimod response and the absence of AD co-pathology, reinforcing confidence in the drug's potential to slow disease progression [2][5] Statistical Findings - Within-participant comparisons showed that at the lowest plasma pTau181 levels (<21 pg/mL), the average change in Clinical Dementia Rating Sum of Boxes (CDR-SB) was -1.11, indicating significant clinical improvement [6][7] - The mean change in the Alzheimer's Disease Cooperative Study — Clinical Global Impression of Change (ADCS-CGIC) score also demonstrated a greater effect at lower pTau181 levels [7][8] Future Plans - The company plans to initiate a global Phase 3 trial in the second half of 2026, focusing on patients with DLB enriched for those without AD co-pathology [16] - The planned trial will utilize a pTau181 cut-off level of <21 pg/mL, estimated to include 80% to 90% of patients without AD co-pathology [8][16]

Industry Overview - The Zacks Audio Video Production industry includes manufacturers of televisions, speakers, video players, camcorders, gaming consoles, drones, and high-end cameras, providing advanced audio, imaging, and voice technologies to enhance entertainment and communication experiences [3] - The industry is experiencing growth driven by technological advancements such as 4K, 8K, and immersive audio formats, alongside the rise of streaming platforms and gaming [4] Key Trends - Technological advancements are a major growth driver, with increasing demand for high-resolution visual and audio experiences fueled by streaming and gaming [4] - The creator economy is boosting demand for enhanced cameras and editing tools, benefiting companies like GoPro [4] - Automotive audio presents a lucrative opportunity as vehicles become more software-driven and experience-focused [4] Market Performance - The industry has underperformed compared to the broader Zacks Consumer Discretionary sector and the S&P 500, losing 13.8% over the past year, while the S&P 500 gained 21.3% [11] - The industry's current forward 12-month P/E ratio is 16.94X, below the S&P 500's 21.57X and the sector's 17.22X [14] Company Highlights Sonos - Sonos is focused on product innovation, with recent launches including the Sonos Play & Era 100 SL speakers, aimed at enhancing user experience [19][20] - The company holds a 6% share of the $24 billion premium audio market and expects second-quarter revenues between $250 million and $280 million, indicating a potential year-over-year decline of 4% to an increase of 8% [21] - Sonos has a Zacks Rank 1 (Strong Buy) and shares have gained 16.8% in the past year [22] Dolby Laboratories - Dolby is seeing strong engagement with its Dolby Atmos and Dolby Vision technologies, with partnerships expanding in the automotive market [23][24] - The company expects fiscal 2026 revenues of $1.4-$1.45 billion, up from $1.35 billion in fiscal 2025 [25] - Dolby carries a Zacks Rank 2 (Buy) but shares have declined 25.5% in the past year [26] LiveOne - LiveOne is focused on cost reduction and debt management, leveraging AI to streamline operations [30] - The company is expanding B2B deals and has seen a 30% increase in its pipeline over the last four months [31] - LiveOne expects fiscal 2027 revenues of $85-$95 million, with a Zacks Rank 2, but shares have fallen 25.7% in the past year [32]

Key Takeaways ACEL, CROX, ALTO and DLB stand out as inflation eases and rate-cut expectations grow.ACEL shows 15% growth outlook, with earnings estimates rising 9.5% in 60 days.ALTO leads with 100% growth forecast, while CROX and DLB also post estimate gains.Inflation eased in January, with prices of goods and services increasing at a slower-than-expected pace. This raised hopes that the Federal Reserve could finally breathe a sigh of relief and may consider easing its monetary policy in the near term.Given ...

Group 1 - Carter's (CRI) is currently outperforming its peers in the Consumer Discretionary sector, with a year-to-date return of 29.3% compared to the sector's average return of -4.6% [4] - The Zacks Rank for Carter's is 1 (Strong Buy), indicating strong analyst sentiment and a positive earnings outlook, with the consensus estimate for full-year earnings increasing by 10.4% over the past three months [3] - Carter's belongs to the Shoes and Retail Apparel industry, which is ranked 89 in the Zacks Industry Rank, and has performed better than this group, which has seen a loss of about 0.6% year-to-date [5] Group 2 - The Consumer Discretionary sector includes 255 individual stocks and currently holds a Zacks Sector Rank of 9, reflecting the average Zacks Rank of the stocks within the sector [2] - Another stock in the Consumer Discretionary sector, Dolby Laboratories (DLB), has a year-to-date return of 0.1% and a Zacks Rank of 2 (Buy), with a consensus EPS estimate increase of 1.4% over the past three months [4][5] - The Audio Video Production industry, where Dolby Laboratories is categorized, has a Zacks Industry Rank of 11 and has declined by 15.7% since the beginning of the year [6]

Group 1: Consumer Confidence and Economic Indicators - Consumer confidence rose by 2.2 points to 91.2 in February, surpassing analysts' expectations of 87 [4][10] - The unemployment rate decreased to 4.3% in January from 4.4% in December, with 130,000 new jobs added [6] - Short-term inflation expectations fell to a 13-month low of 3.5% in February from 4% in January, indicating a potential easing of inflation [7] Group 2: Recommended Consumer Discretionary Stocks - Rush Street Interactive, Inc. (RSI) has an expected earnings growth rate of 43.2% for the current year, with a Zacks Rank of 2 [8] - Crocs, Inc. (CROX) is projected to have a 5.7% earnings growth rate, also holding a Zacks Rank of 2 [11] - Callaway Golf Company (CALY) expects a significant earnings growth rate of 61.9%, with a Zacks Rank of 1 [12] - Dolby Laboratories, Inc. (DLB) anticipates a 1.7% earnings growth rate, currently rated as 2 [14] - MasterCraft Boat Holdings, Inc. (MCFT) has an expected earnings growth rate of 64.1%, holding a Zacks Rank of 1 [15] Group 3: Earnings Estimate Revisions - The earnings estimates for RSI, CROX, CALY, DLB, and MCFT have all improved over the past 60 days, indicating positive market sentiment [3][10]

Core Insights - Dolby Laboratories, Inc. is recognized for its innovative sound technologies and competes with companies like NETGEAR, Inc., Morningstar, Inc., Copart, Inc., and MSC Industrial Direct Co., Inc. in financial performance and capital efficiency [1] Financial Performance - Dolby has a Return on Invested Capital (ROIC) of 8.76% and a Weighted Average Cost of Capital (WACC) of 7.63%, resulting in a ROIC to WACC ratio of 1.15, indicating efficient capital utilization [2][6] - Copart, Inc. leads the group with a ROIC to WACC ratio of 1.65, showcasing superior efficiency in generating returns over its cost of capital [3][6] - Morningstar, Inc. and MSC Industrial Direct Co., Inc. have ROIC to WACC ratios of 1.37 and 1.61, respectively, highlighting their strong capital efficiency [4] - NETGEAR, Inc. has a negative ROIC to WACC ratio of -0.69, indicating inefficiency in generating returns above its cost of capital [5][6]

Core Viewpoint - Dolby Laboratories (DLB) has shown a recent stock price increase of 3.3% over the past four weeks, with a mean price target of $89.25 indicating a potential upside of 40.2% from the current price of $63.65 [1] Price Targets and Estimates - The mean estimate for DLB comprises four short-term price targets with a standard deviation of $19, where the lowest estimate is $68.00 (6.8% increase) and the highest is $114.00 (79.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Analyst Sentiment and Earnings Estimates - Analysts are optimistic about DLB's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a 6.8% increase over the past month with two upward revisions and no negative revisions [11][12] - DLB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows that they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Insights - Neo Ivy Capital Management disclosed a new position in Dolby Laboratories, acquiring 117,964 shares valued at approximately $7.58 million on February 13, 2026 [1][2] Company Overview - Dolby Laboratories is a leading provider of audio and imaging innovations, utilizing proprietary technologies to enhance entertainment experiences across various platforms [6] - The company operates a robust licensing model combined with hardware solutions, which supports global reach and recurring revenue streams [6] - As of February 12, 2026, Dolby's stock price was $66.57, with a market capitalization of $6.37 billion and a revenue of $1.34 billion for the trailing twelve months (TTM) [4] Financial Performance - In the first quarter of fiscal 2026, Dolby reported revenue of $347 million, a decrease from $357 million year-over-year, with $319.8 million derived from high-margin licensing streams [11] - The gross profit for the quarter was $303.5 million, and the company generated $53.3 million in GAAP net income [11] - Dolby repurchased approximately 1 million shares for about $70 million, maintaining a buyback authorization balance of $207 million [11] Market Position - Dolby's licensing franchises are characterized by high gross margins of roughly 90%, and the company holds over $640 million in cash and equivalents, indicating a strong balance sheet [12] - The company serves a diverse clientele, including film studios, content creators, post-production facilities, cinema operators, broadcasters, and device manufacturers globally [9] - Despite a decline of 18.2% in share price over the past year, Dolby's fundamentals suggest a more stable outlook, contrasting with its underperformance relative to the S&P 500 by 31.08 percentage points [8][11]

Economic Overview - Consumer sentiment in the U.S. improved to a six-month high of 57.3 in February, up from 56.4 in January, surpassing the consensus estimate of 55 [3][11] - Despite concerns over high prices and a tightening labor market, consumers remain optimistic about inflation easing in the near future [4][5] Consumer Discretionary Stocks - Recommended stocks include Carnival Corporation & plc (CCL), Dolby Laboratories, Inc. (DLB), Marriott International, Inc. (MAR), and Ralph Lauren Corporation (RL) due to positive earnings estimate revisions and strong Zacks rankings [2] - CCL, the largest cruise operator globally, has an expected earnings growth rate of 12.9% for the current year, with earnings estimates improving by 5.8% over the last 60 days [8][11] - DLB, which focuses on audio and imaging technologies, has an expected earnings growth rate of 0.9% for the current year, with estimates up by 1.9% in the past 60 days [10] - MAR, a leading hospitality company, anticipates earnings growth of 15.7%, with estimates increasing by 1% over the last 60 days [11] - RL, a designer and distributor of premium lifestyle products, expects a significant earnings growth rate of 30.5% for the next year, with estimates improving by 5.2% in the past 60 days [13]